Cargando…
Bufalin Inhibits HCT116 Colon Cancer Cells and Its Orthotopic Xenograft Tumor in Mice Model through Genes Related to Apoptotic and PTEN/AKT Pathways
Aims. To investigate the anticolorectal cancer (CRC) effects of Bufalin, a bioactive polyhydroxysteroid from Venenum Bufonis, using HCT116 human CRC cell and an established orthotopic xenograft model in mice, and to explore the mechanisms of action. Material and Methods. Cultured HCT116 cells or BAL...
Autores principales: | Wang, Jie, Chen, Chao, Wang, Shiying, Zhang, Yong, Yin, Peihao, Gao, Zhongxiang, Xu, Jie, Feng, Dianxu, Zuo, Qinsong, Zhao, Ronghua, Chen, Teng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685085/ https://www.ncbi.nlm.nih.gov/pubmed/26770191 http://dx.doi.org/10.1155/2015/457193 |
Ejemplares similares
-
Bufalin inhibits gastric cancer invasion and metastasis by down-regulating Wnt/ASCL2 expression
por: Wang, Jie, et al.
Publicado: (2018) -
In vivo anticancer activity of a rhodium metalloinsertor in the HCT116 xenograft tumor model
por: Threatt, Stephanie D., et al.
Publicado: (2020) -
A zebrafish HCT116 xenograft model to predict anandamide outcomes on colorectal cancer
por: Maradonna, Francesca, et al.
Publicado: (2022) -
Cytotoxic and apoptotic potential of gemini-chrysophanol nanoparticles against human colorectal cancer HCT-116 cell lines
por: Naqishbandi, Alaadin M.
Publicado: (2022) -
The Effect of Dynamic, In Vivo-like Oxaliplatin on HCT116 Spheroids in a Cancer-on-Chip Model Is Representative of the Response in Xenografts
por: Komen, Job, et al.
Publicado: (2022)